Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2013
12/25/2013CN101652388B Monoclonal human tumor-specific antibody
12/25/2013CN101611054B Humanized antibody against amyloid beta
12/25/2013CN101558082B Targeted binding agents directed to PDGFR-alpha and uses thereof
12/25/2013CN101501070B Antigenic GM-CSF peptides and antibodies to GM-CSF
12/24/2013US8614303 Diagnostic methods for ubiquinated protein profiling
12/24/2013US8614301 Methods of treating cancer using anti CD24 antibodies
12/24/2013US8614300 Nucleic acids encoding a mut-T domain-containing polypeptide
12/24/2013US8614299 Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
12/24/2013US8614298 Humanized anti-amyloid beta antibodies
12/24/2013US8614297 Anti-idiotype antibody against an antibody against the amyloid β peptide
12/24/2013US8614296 Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof
12/24/2013US8614295 Antibody molecules having specificity for human OX40
12/24/2013US8614294 Pyrenyloxysulfonic acid fluorescent agents
12/24/2013US8614289 Processes for the manufacture of macrocyclic depsipeptides and new intermediates
12/24/2013US8614065 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
12/24/2013US8613930 Cross-linkers and their uses
12/24/2013US8613928 Immunizing composition and method for inducing an immune response against the β-secretase cleavage site of amyloid precursor protein
12/24/2013US8613926 Anti-C5a receptor antibodies
12/24/2013US8613924 Antibodies that specifically bind to A beta oligomers and use thereof
12/24/2013US8613923 Monoclonal antibody
12/24/2013US8613903 Humanized L243 antibodies
12/24/2013DE102008033381B4 Modulation der Immunantwort durch den Rezeptor NKp65 und seine Liganden Modulation of the immune response by the receptor NKp65 and its ligands
12/24/2013CA2702582C Feline pancreatic lipase
12/24/2013CA2698667C Human gm-csf antigen binding proteins
12/24/2013CA2555393C Hybrid proteins of active-site serine beta-lactamase
12/24/2013CA2487915C Allergen from mugwort pollen
12/24/2013CA2457461C Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b
12/24/2013CA2397199C Nogo receptor-mediated blockade of axonal growth
12/24/2013CA2375104C Prevention and treatment of amyloidogenic disease
12/24/2013CA2349762C Human tslp dna and polypeptides
12/19/2013WO2013188855A1 Anti-pcsk9 antibodies, formulations, dosing, and methods of use
12/19/2013WO2013188740A1 Anti-psma antibodies conjugated to nuclear receptor ligand polypeptides
12/19/2013WO2013188494A1 Fixed dosage regimens for anti-type i interferon receptor (ifnar) antibodies
12/19/2013WO2013187953A1 Humanized non-human animals with restricted immunoglobulin heavy chain loci
12/19/2013WO2013187724A1 Novel antibody specific for clec14a and uses thereof
12/19/2013WO2013187556A1 Novel antibody specific for clec14a and uses thereof
12/19/2013WO2013187495A1 ANTIGEN-BINDING MOLECULE CONTAINING MODIFIED Fc REGION
12/19/2013WO2013187371A1 Method for detecting cancer, and antibody capable of recognizing pancreas-specific ribonuclease 1
12/19/2013WO2013186777A2 Use of blocking agents of bone morphogenie protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases
12/19/2013WO2013186752A1 Monoclonal antibodies able to bind the viral hcv e2 protein preparation and use thereof
12/19/2013WO2013186719A1 Improved antagonist antibodies against gdf-8 and uses therefor
12/19/2013WO2013186700A1 Antibody formulation
12/19/2013WO2013186630A2 Humanized antibodies to ca215
12/19/2013WO2013186613A1 Humanized antibodies to cluster of differentiation 3 (cd3)
12/19/2013WO2013186541A1 Biomarker for determining the suitability of anti -tumour necrosis factor (anti-tnf) therapy in the treatment of autoimmune diseases
12/19/2013WO2013186236A1 Antagonists of il-17 isoforms and their uses
12/19/2013WO2013185558A1 Polypeptides and antibodies for treating hbv infection and related diseases
12/19/2013WO2013185552A1 Dual-signal independent chimeric antigen receptor and use thereof
12/19/2013WO2013185215A1 Antibodies and conjugates that target misfolded prion protein
12/19/2013WO2013185193A1 Method for producing and obtaining variable domains of anti-digoxin monoclonal antibody fab fragment using the molecular biology cloning technique
12/19/2013WO2013185165A1 Cd-52 antibodies and their use in determining and enhancing an immune response in a subject
12/19/2013WO2013158275A9 Cell culture methods to reduce acidic species
12/19/2013WO2013152860A3 Improved antibody light chains
12/19/2013WO2013142796A3 Methods of treatments using ctla4 antibodies
12/19/2013US20130340102 Humanized antibodies to ca215
12/19/2013US20130340101 Novel Homeobox Gene
12/19/2013US20130338344 Protein purification methods to reduce acidic species
12/19/2013US20130338343 Compositions and methods for treating kidney disease
12/19/2013US20130338339 Affinity chromatography matrix
12/19/2013US20130338091 HUMAN BetaV-TUBULIN ANTIBODY AND METHODS OF USE
12/19/2013US20130337559 Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors
12/19/2013US20130337533 Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt
12/19/2013US20130337505 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
12/19/2013US20130337478 Antigen-Binding Protein Directed Against Epitope in the CH1 Domain of Human IgG Antibodies
12/19/2013US20130337467 P28gank monoclonal antibody and peptides for preparation thereof and use thereof
12/19/2013US20130337039 Internalizing ErBB2 Antibodies
12/19/2013US20130336999 Peptide with reduced dimer formation
12/19/2013US20130336995 Photosensitizing antibody-fluorophore conjugates
12/19/2013US20130336992 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
12/19/2013US20130336991 Sp35 Antibodies and Uses Thereof
12/19/2013US20130336985 Medicament and a method for regulation of the vascular tone
12/19/2013US20130336984 Antagonistic dr3 ligands
12/19/2013US20130336983 Prognosis and treatment of breast cancer
12/19/2013US20130336982 Antagonist antibodies against gdf-8 and uses therefor
12/19/2013US20130336981 Methods and means for the production of ig-like molecules
12/19/2013US20130336980 ST2L Antagonists and Methods of Use
12/19/2013US20130336978 Binding members for interleukin-4 receptor alpha (IL-4Ra) - 173
12/19/2013US20130336977 Single-chain multivalent binding proteins with effector function
12/19/2013US20130336975 Anti-ngf compositions and use thereof
12/19/2013US20130336974 Method for delivering agents into cells using bacterial toxins
12/19/2013US20130336973 Heteromultimer Constructs of Immunoglobulin Heavy Chains with Mutations in the Fc Domain
12/19/2013US20130336972 Recombinant fc-fusion protein of the fifth fibronectin type iii domain of dcc
12/19/2013US20130336971 Homodimeric protein constructs
12/19/2013US20130336970 Compositions and Methods for Treating and Diagnosing Cancer
12/19/2013US20130336967 Anti-bst2 antibody
12/19/2013US20130336964 Anti-trka antibodies, derivatives and uses thereof
12/19/2013US20130336963 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
12/19/2013US20130336957 Novel purification of human, humanized, or chimeric antibodies using protein a affinity chromatography
12/19/2013US20130336926 Il-1 family variants
12/19/2013US20130336923 Carbonic Anhydrase IX (G250) Antibodies and Methods of Use Thereof
12/19/2013US20130336894 Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications
12/19/2013US20130336886 Tumor specific antibodies and uses therefor
12/19/2013US20130336885 Anti-lgr5 antibodies and immunoconjugates
12/19/2013CA2877669A1 Dual receptor antagonistic antigen-binding proteins and uses thereof
12/19/2013CA2877505A1 Antibodies and conjugates that target misfolded prion protein
12/19/2013CA2876796A1 Humanized antibodies to ca215
12/19/2013CA2876706A1 Anti-psma antibodies conjugated to nuclear receptor ligand polypeptides
12/19/2013CA2876636A1 Fixed dosage regimens for anti-type i interferon receptor (ifnar) antibodies
12/19/2013CA2876397A1 Improved antagonist antibodies against gdf-8 and uses therefor
12/19/2013CA2876172A1 Humanized non-human animals with restricted immunoglobulin heavy chain loci
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 1494